Examiner: BAEK, BONG-SOOK

Tech Center 1600 • Art Units: 1611 1614 1621 1624 1627 1629 1693

This examiner grants 42% of resolved cases

Performance Statistics

41.7%

Allow Rate

-18.3% vs TC avg

967

Total Applications

+69.8%

Interview Lift

1139

Avg Prosecution Days

Based on 919 resolved cases, 2023–2026

2.1%

§101 Eligibility

17.4%

§102 Novelty

37.4%

§103 Obviousness

23.5%

§112 Clarity

App #	Title	Status	Assignee
18813414	PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL	Non-Final OA	Allergan, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.